Espicom market intelligence, brought to you by Business Monitor InternationalAngola Pharmaceuticals & Healthcare ReportSince re-election in August 2012, incumbent President Dos Santos has promised considerable investment in Angola's healthcare and pharmaceutical market. With plans for new hospitals announced - including one expansion financed with Chinese funds - as well as the creation of mini laboratories to conduct quality checks on drugs, the government is taking steps to improve healthcare provision. But between these few, concrete projects, many vague proposals remain, with little detail around how they will be implemented or funded. Revised historical trade data has led to a sharp downward revision of the size of Angola's pharmaceutical market this quarter. These new figures have also led to a reduction of the size of Angola's healthcare market - although to a lesser degree. Given the unreliability of official figures, we will continue to monitor trade data and will adjust Angola's market size accordingly.Headline Expenditure Forecasts Pharmaceuticals: AOA17.79bn (US$187mn) in 2012 to AOA20.29bn (US$213mn) in 2013; +14.0% in local currency and +13.8% in US dollar terms.Healthcare: AOA373.72bn (US$3.93bn) in 2012 to AOA433.97bn (US$4.66bn) in 2013; +16.1% in local currency and +15.9% in US dollar terms.Risk/Reward Rating: Angola's Pharmaceutical Risk/Reward Rating (RRR) score for Q213 is unchanged from the previous quarter. This is also the case for all other countries in BMI ' s proprietary system that ranks pharmaceutical markets according to attractiveness to multinational drugmakers. A minor re-weighting of one of the RRR components is being implemented to improve the tool, and the adjusted scores for all markets will be published in the Q313 updates of the Pharmaceuticals & Healthcare reports. Angola has a RRR score of 34.8 out of 100, making it the 26 th most attractive pharmaceutical market in Middle East and Africa. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Angola
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
Angola Pharmaceuticals & Healthcare Report
Since re-election in August 2012, incumbent President Dos Santos has promised considerable investment in Angola's healthcare and
pharmaceutical market. With plans for new hospitals announced - including one expansion financed with Chinese funds - as well as
the creation of mini laboratories to conduct quality checks on drugs, the government is taking steps to improve healthcare provision.
But between these few, concrete projects, many vague proposals remain, with little detail around how they will be implemented or
funded. Revised historical trade data has led to a sharp downward revision of the size of Angola's pharmaceutical market this quarter.
These new figures have also led to a reduction of the size of Angola's healthcare market - although to a lesser degree. Given the
unreliability of official figures, we will continue to monitor trade data and will adjust Angola's market size accordingly.
Headline Expenditure Forecasts
Pharmaceuticals: AOA17.79bn (US$187mn) in 2012 to AOA20.29bn (US$213mn) in 2013; +14.0% in local currency and +13.8% in
US dollar terms.
Healthcare: AOA373.72bn (US$3.93bn) in 2012 to AOA433.97bn (US$4.66bn) in 2013; +16.1% in local currency and +15.9% in US
dollar terms.
Risk/Reward Rating: Angola's Pharmaceutical Risk/Reward Rating (RRR) score for Q213 is unchanged from the previous quarter.
This is also the case for all other countries in BMI ' s proprietary system that ranks pharmaceutical markets according to
attractiveness to multinational drugmakers. A minor re-weighting of one of the RRR components is being implemented to improve the
tool, and the adjusted scores for all markets will be published in the Q313 updates of the Pharmaceuticals & Healthcare reports.
Angola has a RRR score of 34.8 out of 100, making it the 26 th most attractive pharmaceutical market in Middle East and Africa.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 5
SWOT Analysis 7
Angola Pharmaceuticals And Healthcare SWOT 7
Pharmaceutical Risk/Reward Ratings 8
Table: MEA Pharmaceuticals And Healthcare Risk/Reward Ratings, Q113 8
The Pharmaceutical Market: Angola (From Slideshare) Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Rewards 9
Risks 10
Market Summary 11
Regulatory Regime 13
Intellectual Property Issues 13
Pricing And Reimbursement 13
Regulatory Developments 14
Epidemiology 14
Clinical Trials Sector 17
Industry Forecast Scenario 18
Overall Market Forecast 18
Table: Pharmaceutical Sales Indicators, 2008-2016 19
Key Growth Factors ' Industry 20
Table: Healthcare Expenditure Indicators, 2008-2016 22
Table: Healthcare Governmental Indicators, 2008-2016 22
Table: Healthcare Private Indicators, 2008-2016 23
Key Growth Factors ' Macroeconomic 24
Table: Angola ' Economic Activity 27
Key Risks To BMI's Forecast Scenario 28
Competitive Landscape 29
Company Developments 29
Company Profiles 31
Demographic Outlook 32
Table: Angola's Population By Age Group, 1990-2020 ('000) 33
Table: Angola's Population By Age Group, 1990-2020 (% of total) 34
Table: Angola's Key Population Ratios, 1990-2020 35
Table: Angola's Rural And Urban Population, 1990-2020 35
Glossary 36
BMI Methodology 38
How We Generate Our Pharmaceutical Industry Forecasts 38
Risk/Reward Ratings Methodology 39
Ratings Overview 39
Table: Pharmaceutical Business Environment Indicators 40
Weighting 41
Table: Weighting Of Components 41
The Pharmaceutical Market: Angola (From Slideshare) Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Angola
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Angola (From Slideshare) Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Angola (From Slideshare) Page 4/4